WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Arbutus Biopharma earnings were -$77.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ABUS earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$19.8M, up 10.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ABUS reported annual earnings of -$72.8M, with 4.9% growth. The next ABUS earnings date is Nov 5, 2024.

ABUS earnings history

Current Revenue
$10.1M
Current Earnings
-$77.1M
Current Profit Margin
-766.2%

ABUS Return on Equity

Current Company
-66.7%
Current Industry
22.8%
Current Market
33.7%
ABUS's Return on Equity (-66.7%)... subscribe to Premium to read more.
High Return on Equity Performance

ABUS Return on Assets

Current Company
-50.3%
Current Industry
3.5%
ABUS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABUS announces earnings.

ABUS Return on Capital Employed

Current Company
-55.96%
Current Industry
21.3%
ABUS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABUS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABUS-$75.48M-$77.09MN/A-$0.45
ERAS-$154.27M-$158.28MN/A-$0.91
TRML-$36.34M-$35.69MN/A-$1.26
MLYS-$119.65M-$119.67MN/A-$2.73
PLRX-$178.42M-$185.41MN/A-$3.09
View Top Biotech Stocks

ABUS earnings dates

Next earnings date
Nov 5, 2024

Arbutus Biopharma Earnings Reports & History FAQ

What were Arbutus Biopharma's earnings last quarter?

On ABUS's earnings call on Invalid Date, Arbutus Biopharma (NASDAQ: ABUS) reported Q2 2024 earnings per share (EPS) of -$0.11, up 10% year over year. Total ABUS earnings for the quarter were -$19.80 million. In the same quarter last year, Arbutus Biopharma's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.

When does Arbutus Biopharma report earnings?

The next ABUS earnings call is Invalid Date. Add ABUS to your watchlist to be reminded of Arbutus Biopharma's next earnings date.

Is Arbutus Biopharma profitable or losing money?

As of the last Arbutus Biopharma earnings report, Arbutus Biopharma is currently losing money. Arbutus Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$77.09 million, a 5.7% increase year over year.

What was ABUS's earnings growth in the past year?

As of Arbutus Biopharma's earnings date in Invalid Date, Arbutus Biopharma's earnings has grown year over year. ABUS earnings in the past year totalled -$77.09 million.

What are Arbutus Biopharma's earnings expectations?

The current EPS estimate for Arbutus Biopharma's earnings report in Invalid Date is -$0.09.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.